unknown by Tzvi Holtzman et al.
BioMed CentralMicrobial Cell Factories
ssOpen AccePoster Presentations
Production and purification of high molecular weight oligomers of 
Yersinia pestis F1 capsular antigen released by high cell density 
culture of recombinant Escherichia coli cells carrying the caf1 
operon
Tzvi Holtzman*1, Yinon Levy2, Dino Marcus1, Yehuda Flashner2, 
Emanuelle Mamroud2, Sara Cohen2 and Rephael Fass1
Address: 1Department of Biotechnology, Israel Institute for Biological Research, P. O. Box 19, Ness Ziona, 74100, Israel and 2Department of 
Biochemistry and Molecular Genetics, Israel Institute for Biological Research, P. O. Box 19, Ness Ziona, 74100, Israel
* Corresponding author    
Background
Yersinia pestis fraction 1 antigen (F1) is the major compo-
nent of the pathogen capsule. F1, a 15.5 kDa monomer
that forms high molecular oligomers (>1000 kDa), is a
highly protective antigen and is considered as a key con-
stituent of a subunit anti-plague vaccine.
F1 antigen is encoded on the caf1 operon together with a
transcriptional regulator (caf1R), a chaperone (caf1M)
and an usher protein (caf1A) and its expression is induced
by a temperature shift to 37°C. Production and purifica-
tion of F1 protein from Y. pestis cells is a tedious and time
consuming procedure. Use of recombinant Escherichia coli
for the production of F1 was reported [1,3].
Here, we describe an efficient procedure for production
and purification of F1 released from the cell surface of E.
coli cells, carrying the caf1 operon, grown to a high cell
density.
Results
The caf1 operon, derived from Y. pestis Kimberley53 viru-
lent strain [2], was cloned into the medium copy-number
plasmid pBR322-Kanamycin (to yield pBRK-F1), and the
expression plasmid was introduced into Escherichia coli
MC1060. Under expression conditions the cells were
found to produce high levels of F1 as a capsule (Y.L., E.M.,
S.C., Y.F., unpublished data).
Fermentation
Expression of F1 by E. coli MC1060 (pBRK-F1) was stud-
ied in a 4-liter computer-controlled fermentor using a rich
medium devoid of animal products: soy protein extract,
trace elements and glycerol as carbon source (SY). This
medium enabled efficient bacterial growth to a high cell
density (60 OD600, Fig 1A). No loss of the expression plas-
mid was observed under these conditions. Unexpectedly,
high and constant level of F1 expression was observed
throughout the fermentation (up to 24 hours) even at
28°C (no temperature shift to 37°C was required, Fig.
1B). Moreover, at a high cell density (>10 OD600), F1 was
released from the encapsulated E. coli cells and accumu-
lated up to 0.9 g/L in the culture medium (Fig. 1C).
Purification
Following centrifugation, the supernatant containing F1
was micro-filtered through 0.2 μm tangential flow car-
tridges with no apparent yield loss. Native PAGE and size
exclusion chromatography analyses indicated a high
molecular weight of F1 oligomers (>1000 kDa). Despite
the oligomers size, F1 passed through ultra-filtration tan-
gential flow cartridges having nominal pore size of 300
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Expression and release of F1 protein by recombinant E. coli MC1060 (pBRK-F1) during fermentationFigure 1
Expression and release of F1 protein by recombinant E. coli MC1060 (pBRK-F1) during fermentation. Culture growth was fol-
lowed (A), and SDS-PAGE and Western blot analysis were performed on bacterial cell lysates (B, 0.05 OD600/lane), and culture 








Microbial Cell Factories 2006, 5(Suppl 1):P98and 100 kDa and could be finally concentrated using
ultra-filtration cartridges of 50 kDa (Fig. 2).
Further purification steps were as follows: (a) 33% satura-
tion ammonium sulfate precipitation, (b) size exclusion
chromatography and (c) endotoxin removal resulting in
at least 3-log reduction of endotoxin content, to ~200 EU/
ml. The highly purified F1 antigen (>90%) consisted of
high molecular oligomers with final recovery yield of 14%
(125 mg F1/L culture).
Conclusion
1. E. coli cells expressing F1 could be grown to a high cell
density in SY medium at 28°C, using a computer-control-
led fermentor.
2. Continuous high level expression of F1 protein by
recombinant E. coli was achieved during fermentation
with no plasmid loss.
3. F1 antigen was massively released from the encapsu-
lated cells at high cell density cultures.
4. High molecular weight oligomers of F1 were purified to
>90% following few purification steps. This preparation
was used for vaccination experiments in animal models.
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Purification process of rF1 antigenFigure 2
Purification process of rF1 antigen. (1) Fermentation culture supernatant. (2) 0.2 μm micro-filtration filtrate. (3) 50 kDa ultra-
filtration retentate. (4) 33% ammonium sulfate precipitate. (5) Flow-through of Superdex-200 size-exclusion chromatography. 
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